Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2022-10-07 2021-04-07
Drug Identification Number 02419173 02419173
Brand name JAMP-METHOTREXATE JAMP-METHOTREXATE
Common or Proper name Methotrexate Methotrexate
Company Name JAMP PHARMA CORPORATION JAMP PHARMA CORPORATION
Ingredients METHOTREXATE METHOTREXATE
Strength(s) 25MG 25MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRA-ARTERIAL INTRAMUSCULAR INTRATHECAL INTRAVENOUS INTRA-ARTERIAL INTRAMUSCULAR INTRATHECAL INTRAVENOUS
Packaging size 5x2mL 5x2mL
ATC code L01BA L01BA
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-12-01 2020-12-01
Estimated end date 2023-06-30 2022-12-30
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments